Evaluating Buspirone to Treat Opioid Withdrawal

NCT05511909 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder
Opioid Withdrawal
Opioid Craving
Anxiety

Interventions

DRUG: Buspirone
DRUG: Lofexidine
DRUG: Placebo

Sponsor

University of Maryland, Baltimore